Please provide your email address to receive an email when new articles are posted on . Dermatologists should avoid the removal of benign nevi from children that are not of a consenting age, ... ascopubs.org: Development and validation of a gene expression signature to distinguish malignant melanoma from benign nevi.

Context Explanation

Development and validation of a gene expression signature to distinguish malignant melanoma from benign nevi. Medical Xpress: Novel strategy using microRNA biomarkers can distinguish melanomas from nevi The dysplastic nevus initially was described in the 1980s as a mole with increased risk of developing melanoma and requiring total removal. However, dermatopathologists now consider dysplastic nevi to ... About a third of melanomas begin with benign moles.

Insight Material

Now, researchers at Massachusetts General Hospital have found an immune mechanism for these noncancerous skin cells that they believe could be ... PBS: Doctors Finally Decide When a Mole Is Benign and When It's Cancerous Doctors Finally Decide When a Mole Is Benign and When It's Cancerous